chrisvoncsefalvay/vaers-outcomes huggingface dataset:
aches and pains for several days; This case was reported by a consumer via call center representative and described the occurrence of pain in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced pain. On an unknown date, the outcome of the pain was unknown.   It was unknown if the reporter considered the pain to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The age group was not reported but it was selected as an adult as per vaccine indication. The patient enquired that how long do the side effects, aches and pains last, for several days. No other information was available.
pt recv vax & sibling recv vax 13FEB97;20FEB97 pt devel herpes zoster;the reporter was unsure if the pt exp was r/t vax w/varicella;
I am having pulsatile tinnitus since April 17 (more than 1 month after I got my second short of Moderna on March 8). I have never had tinnitus before. It is still ongoing today (April 20) and it appears to get worse.
Moderate to severe joint pain, muscle pain & spasms, low-grade fever, chills, fatigue.  Reaction continuing 4 days after onset.
This pt had pneumonia vaccine 11/22/1989 with no reactions. She had /// again 5/15/06 and within 24 hours developed swelling of upper arm in area where she received it. The arm still swelling, 1 week later and there is some residual redness of upper arm as of 6/7/06.
Scared about getting the 2nd vaccine; Vertigo; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VERTIGO (Vertigo) and ANXIETY (Scared about getting the 2nd vaccine) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Allergy to Sulfa drugs).    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced VERTIGO (Vertigo). On 26-Feb-2021, the patient experienced ANXIETY (Scared about getting the 2nd vaccine). At the time of the report, VERTIGO (Vertigo) had not resolved and ANXIETY (Scared about getting the 2nd vaccine) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: fine (Negative) Fine.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. Treatment medications were unknown.
Systemic: Approximately 1 hr after injection 98 y/o pt became unresponsive. He had a strong pulse, cold extremeties. Did not admin epi. Nurse director felt it was coincidental to injection (hydration/nutrition)-Severe
Major Dizziness and Vomiting; Major Dizziness and Vomiting; Continue to get pings throughout body and across the chest; Body Temperature stays 1.5 degree hotter than normal.; Major joint pain mainly in legs and groin; Constant ache and pain and chills; Constant ache and pain and chills; This is a spontaneous report from a contactable consumer (patient). A 52-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Right on 26Aug2021 12:00 (Batch/Lot Number: EW1072) as single dose for COVID-19 immunisation (age at vaccination was 52-year-old). Medical history was none. Patient had no known allergies. There were no concomitant medications. The patient experienced major dizziness and vomiting. Patient went to ER and they tested him for heart attack, stroke and ran blood work. No Conclusions sent him home. Body temperature stayed 1.5 degree hotter than normal. Major joint pain mainly in legs and groin. Constant ache and pain and chills. Mainly at night. Continue to get pings throughout body and across the chest. Events onset on 10Sep2021 at 16:45. Patient underwent nasal swab on 15Sep2021: negative. Elected not to get 2nd dose. Doctor advised to wait max weeks and get 2nd dose. Concern that 2nd dose would make the dizziness worse. This really stinks. Patient was 52 years old and had never felt this bad since after the vaccine.   Therapeutic measure was taken as a result of dizziness included medicine to stop the dizziness. Outcome of the events was recovered/resolved with sequel.  Follow-up attempts are completed. No further information is expected.
This spontaneous report was received from the patient's mother refers to a 4 year old (also reported as "3 and a half years old") male patient. Concurrent conditions, medical history and allergies were not reported. On an unspecified date approximately in 2011, the patient received the first dose of (Merck) VARIVAX, strength, dose, route, frequency, anatomical location, lot number and expiration date were not reported), when he was one and a half years old. The patient however experienced a mild case of chickenpox where there was an outbreak at his preschool in the spring of 2014 when the patient was three and a half years of age (conflicting information). Patient's mother took the patient to this physician and the patient was vaccinated with (Merck) VARIVAX, (strength, dose, route, frequency, anatomical location, lot number and expiration date were not reported), second dose at three and a half years of age (conflicting information). Lab diagnostics studies were not performed and treatment was not given. No further information was provided. The outcome of the above mentioned events was unknown. Additional information is not expected, patient's mother and physician contact information were not provided.
3 days p/vax pt devel diffuse massive urticaria, fever, edema of face & extremities;
Covid booster given on 9/27/21.  No adverse reactions with 1st 2 in series or this one.   1 week later 10/4/21, received Fluzone lot # UT73JA,   10-11 days following Fluzone vaccine... diagnosed with Bell's Palsy.  treated with steroids and antiviral.   Now resolved.
Pt. felt groggy, sluggish on a.m. of 3-4-04 temp 99.3 on3-4-04, right arm red, swollen, and warm at touch, firm to touch from shoulder to elbow.  Physician reviewed, start Benadryl, per dosage in chart.
Received a Cortisone injection in toe after first dose for unknown cause; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (Received a Cortisone injection in toe after first dose for unknown cause) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (Received a Cortisone injection in toe after first dose for unknown cause). The patient was treated with CORTISONE on 01-Mar-2021 for Adverse event NOS, at an unspecified dose and frequency. At the time of the report, ADVERSE EVENT (Received a Cortisone injection in toe after first dose for unknown cause) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       It was reported that the patient was due to receive the second dose of the Moderna Covid-19 vaccine on 03 Mar 2021.  No concomitant medications were reported.
Cervical spine area surgery; sore left arm for 24 hours after the first Covid-19 vaccine; This spontaneous case was reported by a consumer and describes the occurrence of SPINAL OPERATION (Cervical spine area surgery) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Surgery (The patient had been in the hospital for cervical spine area surgery 2 weeks before second dose.).    On 30-Mar-2021 at 9:15 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, the patient experienced VACCINATION SITE PAIN (sore left arm for 24 hours after the first Covid-19 vaccine). In April 2021, the patient experienced SPINAL OPERATION (Cervical spine area surgery) (seriousness criterion hospitalization). The patient was hospitalized on sometime in April 2021 due to SPINAL OPERATION. The patient was treated with DIPHENHYDRAMINE, PARACETAMOL (EXTRA STRENGTH TYLENOL PM) in April 2021 for Adverse event, at a dose of 2 tablets. At the time of the report, SPINAL OPERATION (Cervical spine area surgery) and VACCINATION SITE PAIN (sore left arm for 24 hours after the first Covid-19 vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was provided. COMPANY COMMENT: This is an spontaneous case concerning an 39-year-old female patient with no clinical history who experienced the unexpected event of SPINAL OPERATION and a non-serious event The events occurred unknown days after first dose of mRNA-1273. The rechallenge was not applicable since only information about first dose was disclosed The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.   This case was linked to MOD-2021-409876, MOD-2021-409877 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 13-Dec-2021: Follow-up information included no new information.; Sender's Comments: COMPANY COMMENT: This is an spontaneous case concerning an 39-year-old female patient with no clinical history who experienced the unexpected event of SPINAL OPERATION and a non-serious event The events occurred unknown days after first dose of mRNA-1273. The rechallenge was not applicable since only information about first dose was disclosed The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
10/12/22 I felt tired with a slight headache which started that evening, lasted for a few days.  I woke up on 10/15/22 with light headedness and dizziness. I went to Urgent care and the physician felt it could be related to a sinus infection/virus that was still lingering. She took my blood pressure, checked ears and throat, pulse ox and everything was fine. She said it could be from the vaccine, that I could feel effects from the vaccine for up to 5 days, but she still felt it was the virus. She told me to use Flonase and prescription for Meclizine which I took for a few days. 10/16/22 I was a lot better and was able to get out of the house. All the dizziness subsided within a day.
shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a currently 76-year-old female patient. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On an unspecified date in 2012, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) lot#, expiration date, dose, dose# and route of administration not specified) by a pharmacist at a pharmacy for the long-term prevention of shingles and zoster-related conditions. On an unknown date, the patient experienced shingles and was treated by a healthcare provider for the event. The outcome of shingles was unknown. The reporter considered shingles to be related to Zoster Vaccine Live (ZOSTAVAX).
This spontaneous report as received from a pharmacist refers to an unspecified number of patients of unknown demographics. Patient's pertinent medical history, concurrent condition, concomitant medication and previous drug reactions/ allergies were not reported. On an unknown date, these patients were vaccinated with improperly stored doses of ZOSTAVAX lot # M037015, expiry date 22-NOV-2017, for prophylaxis (strength, dosing details and anatomical location were unknown). No adverse symptoms were reported. The vaccines were exposed to the temperature of 29.8 F. The vaccines had previous temperature excursions. No data logger was involved. Additional information has been requested.
Headache, Myalgia, Fever, CoughWheeze, Diarrhea, NauseaVomiting, right arm swelling from injection site to wrist, chills, sweats, dizziness, sore throat, loss of taste/smell, SOB Narrative: Tested for COVID, RSV, Flu B, Flu A on 5/9/22 and all were negative.
Presented to ER with fever and vesiculo-papular rash on trunk, spreading to thighs.
been overcoming a cold. She's starting to feel better but still has cough and congestion; Cough; congestion; This is a spontaneous report from a contactable consumer (Patient). A 59-year-old female patient received BNT162B2 (PFIZE-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), Solution for injection, via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient had been overcoming a cold. She was starting to feel better but still has cough and congestion. The outcome of event cold was recovering, and outcome of all other event was not recovered.  Follow-up attempts are completed. No further information is expected.
Patient was referred to emergency department by primary care physician for concerns of sepsis. Patient UA outpatient that showed a urinary tract infection and was experiencing hypotension. During screening for admission, was found to be COVID-19 positive. Patient was asymptomatic for COVID-19 infection at presentation and was only recieving supportive care. She does not require antiviral, steroid, or supplemental oxygen at time of writing. Patient is currently admitted at time of writing.
Severe sore throat, primarily tonsils and especially on the left side. Hard to swallow, very painful. No other symptoms such as fever, chills, aches, runny nose, cough, nausea, loss of appetite or smell, etc. -- just the sore throat
Customer / received / first dose greater than a year ago / has not received the second dose yet; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 79-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose over a year ago).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows:  The age at vaccination was not applicable for this report. Till the time of reporting patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The health care professional did not have more information. The reporter did not consent to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021111509:Same reporter.
Patient was mistakenly administered a 3rd dose of the Pfizer COVID-19 vaccine
Vaccine administered after temperature excursion; Vaccine administered after temperature excursion; This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after temperature excursion) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 02-Apr-2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after temperature excursion) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication details were provided. No treatment medication details were provided.
REALLY TIRED; FATIGUE LIKE WALKING FOR A MILE; SWEATY FOR 20 MINUTES AFTER THEN HE WAS FINE; This spontaneous report received from a patient concerned a 59 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: penicillin allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A expiry: 9320) dose was not reported, administered on 07-APR-2021 13:30 for prophylactic vaccination. No concomitant medications were reported. On 07-APR-2021, the patient experienced sweaty for 20 minutes after then he was fine. On 08-APR-2021, the patient experienced really tired. On 08-APR-2021, the patient experienced fatigue like walking for a mile. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sweaty for 20 minutes after then he was fine on 07-APR-2021, and really tired, and fatigue like walking for a mile on 09-APR-2021. This report was non-serious.
This case was reported by a physician via call center representative and described the occurrence of extra dose administered in a 63-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 1st and 2nd dose on an unknown date). On 3rd December 2021, the patient received the 3rd dose of Shingrix. On 3rd December 2021, unknown after receiving Shingrix, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown. Additional details were provided as follows: The patient received 3rd dose of Shingrix, which led to extra dose administered. The reporter consented to follow up. This case was linked with case US2021257810, reported by same reporter for different patient.; Sender's Comments: US-GLAXOSMITHKLINE-US2021257810:same reporter.
Extreme stutter, new onset.  Mild developmentally appropriate stutter prior to vaccine.  Extreme stutter lasted 8 days.  Stutter is still more than normal at time of completing this form. Very irritable, and highly distracted ("zoned out"), poor sleep with early waking  x8 days.  (Again, significant difference from baseline).  Mild versions of these above baseline are also still present as I complete this form.
SHINGLES; FLU LIKE SYMPTOMS; This spontaneous report received from a patient concerned a 63 year old female. The patient's weight was 87 pounds, and height was 60 inches. The patient's past medical history included hives, and concurrent conditions included lymphedema in left leg, bronchiectasis, abstain from alcohol, and non smoker, and other pre-existing medical conditions included the patient had no drug abuse or illicit drug usage. The patient experienced drug allergy when treated with amoxicillin/clavulanic acid, clarithromycin, and doxycycline.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown) dose was not reported, administered on 10-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 11-MAR-2021, the subject experienced flu like symptoms. On 09-JUN-2021, the subject experienced shingles. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from flu like symptoms on 12-MAR-2021, and had not recovered from shingles. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required per standard procedure as the case assessed as non-serious.
Patient stated had progressive symptoms of fever, wheezing, cough, sore arm, fever broke 2 am next day, had to take work day off.
Severe congestion at night, aches, headache, mild fever, "flu-like symptoms" lasting roughly 1 day. Injection in afternoon, woke up miserable next morning, felt bad all day, mild arm pain the next day.
Shivering, hoarseness, chest tightness for about 12 hours. Took some BENADRYL and she thinks that might have helped.
Pt felt itching Benadryl 25mg given PO.  Pt had her own and reported taking  Benadryl 25mg before vaccine as well.
Physician Discharge Summary   Patient ID:  79 y.o.    Admit Date:  8/8/2022   Discharge Date:   8/11/2022   Discharge Diagnosis:  Principal Problem:   Pneumonia due to COVID-19 virus Active Problems:   Essential hypertension   Paroxysmal atrial fibrillation     Hospital Course:  79 year old female was admitted for Covid-19 pneumonia and treated with Remdesivir and steroids. Cardiology was involved for a fib with RVR. Rate became controlled later and she was started on anticoagulation. TTE showed normal LVEF. She is stable now and will be discharged home with NOAC and to resume Quinidine to keep the HR under control. Patient educated on appropriate level of care post-discharge. Follow up with Primary Care Doctor in 5-7 days.   Physical Exam on the day of discharge: Last Recorded Vital Signs: Temp: 97.9 °F (36.6 °C) Heart Rate (Monitor): 103 Pulse: 78 BP: (!) 129/94 Respirations: 18 SpO2: 99 % O2 Flow Rate (l/min): 0 l/min General Appearance: no distress  Eyes: PERRLA ENT: moist mucus membranes, no adenopathy Lungs: clear to auscultation bilaterally  Heart: irregular rate and rhythm Abdomen: soft, non-tender  Skin: No rashes or lesions  Extremities: full ROM Neuro: alert, normal strength and tone    Consults:  IP CONSULT TO DIETARY IP CONSULT TO SOCIAL WORK IP CONSULT TO CARDIOLOGY   Significant Diagnostic Studies:   TTE, CT thorax   Operations: none   Disposition:  Home
Information has been received from a registered nurse at a pharmacy clinic concerning a 69 year old male with no pertinent medical history and no drug reactions or allergies who on 08-JUL-2011 was vaccinated SC with a 0.65 ml dose of ZOSTAVAX (Merck) (lot # 670616/0617AA). Concomitant therapy included aspirin 325 mg.  On 08-JUL-2011 the patient experienced significant bruising and pain on the underside of the arm in which he received ZOSTAVAX (Merck), causing the patient to have difficulty lifting his left arm and completing "activities of daily living". The bruise was reported to be about the size of the "palm of the patient's hand". The nurse had referred the patient to be seen by his primary care physician to follow up on his condition. At the time of this report, the patient had not recovered from the events and the events did not improve. Having difficulty lifting his left arm and completing "activities of daily living" were considered to be disabling. Additional information has been requested.
Fever started the night of vaccination and pt. did not sleep well.  His fever resolved with tylenol, but he is still weak and lethargic.